malondialdehyde has been researched along with Gout in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, J; Li, C; Li, Y; Lin, F; Ma, S; Wang, S; Xie, Y; Xu, L; Zhang, Y; Zhao, Y | 1 |
| Du, J; Du, LJ; Jiang, XL; Li, M; Yang, QB; Zhou, JG | 1 |
2 other study(ies) available for malondialdehyde and Gout
| Article | Year |
|---|---|
Paeonia × suffruticosa Andrews leaf extract and its main component apigenin 7-O-glucoside ameliorate hyperuricemia by inhibiting xanthine oxidase activity and regulating renal urate transporters.
Topics: Animals; Apigenin; Creatinine; Glucosides; Gout; Hyperuricemia; Kidney; Malondialdehyde; Mice; Molecular Docking Simulation; Organic Anion Transporters; Oxonic Acid; Paeonia; Superoxide Dismutase; Uric Acid; Xanthine Oxidase | 2023 |
Plasma paraoxonase-1, oxidized low-density lipoprotein and lipid peroxidation levels in gout patients.
Topics: Adult; Antioxidants; Aryldialkylphosphatase; Gout; Humans; Lipid Peroxidation; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidants; Superoxide Dismutase | 2011 |